Gaurav Shah - Feb 14, 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Stock symbol
RCKT
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 04:05 PM
Previous filing
Nov 16, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Options Exercise $0 -46.8 K -7.53% $0.00 575 K Feb 14, 2024 Direct F1
holding RCKT Common Stock 208 K Feb 14, 2024 By Spouse
holding RCKT Common Stock 198 K Feb 14, 2024 By Gaurav D. Shah Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Restricted Stock Units Options Exercise $0 -7.98 K -20% $0.00 31.9 K Feb 14, 2024 Common Stock 7.98 K Direct F2, F3
transaction RCKT Restricted Stock Units Options Exercise $0 -38.8 K -33.4% $0.00 77.5 K Feb 14, 2024 Common Stock 38.8 K Direct F2, F4

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.
F4 One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.